Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Stadtmauer, EA; Larson, RA; Sievers, EL; Estey, EH; Lowenberg, B; Leopold, LH; Berger, MS; Herbertson, R; Appelbaum, FR

Published Date

  • November 16, 2002

Published In

Volume / Issue

  • 100 / 11

Start / End Page

  • 339A - 339A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 44th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • PHILADELPHIA, PENNSYLVANIA

Conference Start Date

  • December 6, 2002

Conference End Date

  • December 10, 2002